Legal NewsRoom
Menu
Menu
LEGAL NEWS
HOT TOPICS
LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Bankruptcy
California
Climate Change
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Corporate
Criminal Law and Procedure
Energy
Environmental
Estate and Elder Law
Family Law
Financial Fraud Law
Florida
Fracking and Alternative Energy
Health Care
Hot Topics
Hurricane Sandy
Illinois
Immigration Law
Immigration Reform
Insurance Law
Intellectual Property
International Law
International Trade
Labor and Employment Law
Law360
Legal Business
Lexis® Hub
Litigation
Mealeys
Media and Entertainment
Mergers and Acquisitions
New Jersey
New York
Pennsylvania
Public Contracts
Public media
Public Policy
Real Estate Law
Securities
Sports Law
Tax Law
Technology
Texas
Top Emerging Trends
Torts
Virtual Currency
Workers' Compensation
NEWS & INSIGHT
Blogs and Newsletters
BIZ Blog
Blog Mosaic
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
LexTalk
State Net
®
Capitol Journal
News & Trending Topics
Law360
Legal Insights & Trends
Lexis Practice Advisor Journal
Professional Communities
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
LexisNexis
®
for Developers
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Search
Search
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Sign In
Browse By Tags
Apotex Corp.
brachytherapy
breast cancer
C.R. Bard
cancer drug
drug maker
enlarged prostate glands
Hospira Inc.
lawsuit
Litigation
medical device
Office of Inspector General
Patent
radiation therapy
Sanofi-Aventis
Taxotere
U.S. Attorney's Office for the Northern District of Georgia
U.S. Department of Health and Human Services
U.S. Securities and Exchange Commission
Tom Moylan
over 11 years ago
Litigation
Litigation Blog
C.R. Bard Takes $51 Million Charge, Agrees To Settle Federal Civil, Criminal Probes
MURRAY HILL, N.J. - (Mealey's) C.R. Bard Inc. on Jan. 27 reported that it has taken a $51 million charge in connection with a preliminary agreement with the civil and criminal divisions of the U.S. Attorney's Office for the Northern District of...
LexisNexis Litigation Resource Community Staff
over 12 years ago
Litigation
News Headlines
Sanofi Loses Cancer Drug Patent Fight In Delaware
WILMINGTON, Del. - (AP) A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere. Full version available to lexis.com subscribers .